Hello Mayank,
Thoughtful portfolio construction what is your theses behind Jublient agro can you brief me please
adhesive play? already pidilite is market leader and Euro is there you think jublient will take some share from them?
and also you are bullish on there agri and polymer business(expecting uptick after US tariff saga gets over ).. Brief me in details
Thanks
after demerger i am not going to hold agri business,I like their adhesive business they are doing quite good with their brand jivanjor . I am from MP i recent saw ( already pidilite is market leader and Euro is there you think jublient will take some share from them?)they are doing it. In my check they are available on almost every store.And due to my carpenter i also have to use it 
.
| NSE Code | Allocation (%) |
|---|---|
| ATHERENERG | 14.01 |
| LAURUSLABS | 12.08 |
| THYROCARE | 7.74 |
| INTELLECT | 7.23 |
| SANSERA | 6.32 |
| MEDPLUS | 6 |
| RACLGEAR | 4.47 |
| SAMHI | 4.43 |
| GRANULES | 3.4 |
| JAYNECOIND | 2.93 |
| RAJRATAN | 2.93 |
| MMFL | 2.89 |
| INDUSTOWER | 2.88 |
| ENTERO | 2.83 |
| MOLDTKPAC | 2.19 |
| PRIVISCL | 2.19 |
| ANDHRSUGAR | 1.83 |
| GANECOS | 1.72 |
| SOLARA | 1.65 |
| ORIENTBELL | 1.54 |
| APOLLOPIPE | 1.53 |
| SATIA | 1.52 |
| RATEGAIN | 1.49 |
| PRAJIND | 1.22 |
| ARVINDFASN | 1.2 |
| BCONCEPTS | 0.9 |
| NEWGEN | 0.89 |
| Stock Name | ALLOCATION |
|---|---|
| Ather Energy Ltd | 12.37 |
| Laurus Labs Ltd | 10.02 |
| Thyrocare Technologies Ltd | 7.21 |
| Intellect Design Arena Ltd | 7.06 |
| Sansera Engineering Ltd | 5.48 |
| MedPlus Health Services Ltd | 5.45 |
| Samhi Hotels Ltd | 4.91 |
| Jayaswal Neco Industries Ltd | 3.48 |
| RACL Geartech Ltd | 3.38 |
| Rajratan Global Wire Ltd | 3.36 |
| MM Forgings Ltd | 3.35 |
| Deepak Fertilizers and Petro Corp | 3.19 |
| Piramal Pharma Ltd | 3.10 |
| Ganesha Ecosphere Ltd | 2.35 |
| Entero Healthcare Solutions Ltd | 2.44 |
| Advanced Enzyme Technologies | 2.31 |
| Andhra Sugars Ltd | 2.32 |
| Mold-Tek Packaging Ltd | 2.21 |
| Venus Pipes and Tubes Ltd | 2.01 |
| Pennar Industries Ltd | 1.95 |
| Apollo Pipes Ltd | 1.80 |
| RateGain Travel Technologies | 1.66 |
| National Fertilizers Limited | 1.64 |
| Satia Industries Ltd | 1.62 |
| Solara Active Pharma Sciences | 1.62 |
| Orient Bell Ltd | 1.62 |
| Praj Industries Ltd | 1.20 |
| Newgen Software Technologies | 0.91 |
| 100.00 |
"My portfolio is currently performing well and is sitting near an All-Time High (ATH). I recently calculated my XIRR, which stands at 26.15%.
My journey began in 2019 with very small amounts, but I only started approaching the markets with serious intent from 2022 onwards. Like most investors, I made my fair share of mistakes early on; however, the practice of gradually scaling up my capital helped me survive the learning curve without permanent damage.
Over the last few years, my style has evolved significantly. I’ve transitioned from a purely fundamental approach to a techno-fundamental one. Blending chart structures with business fundamentals has significantly improved my entry/exit precision. Additionally, I look for ‘Deep Value’ opportunities where there is a clear catalyst for a PE re-rating.
More than the financial gains, I’ve developed a deep passion for the process. Investing has become my primary lens for understanding how global businesses operate and how the world is interconnected."
I am sharing the current composition and broader structural view of my portfolio. My investment thesis centers heavily around two primary themes: Exporters (benefiting from global supply chain shifts and specialized manufacturing) and Essentials (businesses dealing in structural consumption, healthcare, and critical inputs).
From a techno-fundamental framework, almost all these companies possess strong technical setups and are riding active sector-specific tailwinds.
| Stock Name | Allocation (%) |
|---|---|
| Nippon India ETF Gold BeES | 14.02% |
| Ather Energy Ltd | 13.08% |
| Sansera Engineering Ltd | 7.39% |
| Laurus Labs Ltd | 6.52% |
| RACL Geartech Ltd | 5.39% |
| Venus Pipes and Tubes Ltd | 4.77% |
| Thyrocare Technologies Ltd | 4.57% |
| RateGain Travel Technologies Ltd | 4.28% |
| Goodluck India Ltd | 3.81% |
| Balaji Amines Ltd | 3.71% |
| Granules India Ltd | 3.60% |
| KDDL Ltd | 3.52% |
| Universal Cables Ltd | 3.13% |
| Solara Active Pharma Sciences Ltd | 3.06% |
| Akums Drugs and Pharmaceuticals | 2.90% |
| Sheela Foam Ltd | 2.89% |
| Rajratan Global Wire Ltd | 2.85% |
| Gland Pharma Ltd | 2.80% |
| Cyient DLM Ltd | 2.76% |
| MedPlus Health Services Ltd | 2.56% |
| Piramal Pharma Ltd | 2.39% |
| Total | 100.00% |
The Core Themes: Exporters & Essentials
Exporters: A significant chunk of capital is positioned in high-end manufacturing, specialized auto-ancillaries, and global tech service enablers (e.g., Sansera Engineering, RACL Geartech, Rajratan Global Wire, and RateGain). These companies are capturing structural market share shifts overseas.
Essentials (Healthcare & Consumption): I maintain a highly concentrated bet on the broader healthcare value chain—spanning diagnostics, domestic pharmacy retail, API manufacturing, and contract manufacturing (CDMO/CMO) via players like Laurus Labs, Thyrocare, Granules, Akums Drugs, MedPlus, and Piramal Pharma.
Techno-Fundamental Alignment
Rather than focusing purely on value traps, I look for businesses showing strong earnings traction or structural changes that are heavily supported by technical price action.
The vast majority of the portfolio consists of companies that are structurally healthy on the charts, undergoing accumulation phases, or actively breaking out into strong sectors experiencing industry-wide tailwinds.
Macro Hedge
What is your thesis for universal cables?
Universal Cables’ massive ₹550 crore organic capacity expansion is going live in phases, with full commercial integration expected by the end of September 2026.
The rollout timeline for the specific segments reveals where things stand:
Low Voltage (LV) Cable Plant (Satna): This facility was completed and went live for commercial production at the end of February 2026.
Continuous Catenary Vulcanization (CCV) Lines (for MV/HV cables):
Lines 1 & 2: Commissioned earlier and hit near-maximum capacity utilization.
Line 3: Slated to go live by the end of May 2026.
Line 4: Encountered minor equipment delivery delays and is scheduled to be commissioned by September 2026.
Portfolio Update & Reflection
The portfolio has rebounded ~47% from the March lows, primarily driven by strong moves in Thyrocare, Laurus Labs, Ather Energy, and Sansera Engineering.
Recent operational adjustments and rebalancing rationales include:
Exits & Trims: Completely exited Thyrocare and trimmed positions in Laurus Labs and Sansera Engineering to lock in gains where valuations ran ahead of fundamentals.
New Additions: Initiated starter/tracking allocations in select businesses following the latest quarterly earnings reports.
Current Strategy: Balancing high-conviction quality bets with trend momentum, letting winners run while actively trimming frothy valuations.
Current Portfolio Allocation
| Company Name | Ticker | Allocation (%) |
|---|---|---|
| Ather Energy Ltd | ATHERENERG | 13.30% |
| Nippon India ETF Gold BeES | GOLDBEES | 11.06% |
| Sansera Engineering Ltd | SANSERA | 6.21% |
| RACL Geartech Ltd | RACLGEL | 4.89% |
| Ramkrishna Forgings Ltd | RKFORGE | 4.78% |
| Jubilant Ingrevia Ltd | JUBLINGREA | 4.64% |
| Laurus Labs Ltd | LAURUSLABS | 4.37% |
| Balaji Amines Ltd | BALAMINES | 4.29% |
| Venus Pipes & Tubes Ltd | VENUSPIPES | 4.04% |
| KDDL Ltd | KDDL | 4.04% |
| Gland Pharma Ltd | GLAND | 3.96% |
| RateGain Travel Technologies Ltd | RATEGAIN | 3.90% |
| Goodluck India Ltd | GOODLUCK | 3.34% |
| Granules India Ltd | GRANULES | 3.24% |
| Solara Active Pharma Sciences Ltd | SOLARA | 3.22% |
| Universal Cables Ltd | UNIVCABLES | 3.13% |
| Akums Drugs and Pharmaceuticals Ltd | AKUMS | 2.94% |
| Rajratan Global Wire Ltd | RAJRATAN | 2.81% |
| Piramal Pharma Ltd | 543635 | 2.49% |
| Cosmo First Ltd | COSMOFIRST | 2.20% |
| Cyient DLM Ltd | CYIENTDLM | 2.12% |
| Apcotex Industries Ltd | APCOTEXIND | 1.09% |
| Orient Bell Ltd | ORIENTBELL | 1.07% |
| Windlas Biotech Ltd | WINDLAS | 1.03% |
| Entero Healthcare Solutions Ltd | ENTERO | 1.01% |
| Mold-Tek Packaging Ltd | MOLDTKPAC | 0.83% |
| Total | 100.00% |
Key Learnings & Looking Forward
With benchmark indices remaining largely range-bound over the last couple of years, alpha generation has been driven primarily by stock-specific quarterly earnings execution and disciplined risk management. Dis.Invest and biased
The portfolio where generating sustainable alpha requires balancing operating earnings visibility with active risk management.
Managing Hyper-Growth Momentum & Valuation (Ather Energy):
Began systematically trimming Ather Energy into market strength.
Execution Philosophy: When high-momentum leaders transition along their growth S-curve, institutional liquidity frequently drives multiples beyond traditional fair value. Rather than an outright exit that risks premature truncation of a secular winner, scaling out incrementally locks in substantial capital gains while letting the residual high-conviction core compound on “house money.”
Complete Exits (Cleaning the Tail):
New Additions & Diversification:
Motilal Oswal Nifty 500 Momentum 50 ETF (MOMENTUM50): Added a ~3.3% allocation as a systematic, rule-based factor overlay to capture market trends without single-stock tracking overhead.
Aarti Pharmalabs (AARTIPHARM): Initiated a tracking position (~1.0%) to gain exposure to specialized API/CDMO chemistry opportunities.
Scale-Ups & Core Additions:
Profit Taking / Position Right-Sizing:
Defined-Risk Macro Insurance:
| Sector / Pillar | Company / Asset | Ticker | Allocation (%) |
|---|---|---|---|
| Commodity / Hedge | Nippon India ETF Gold BeES | GOLDBEES |
15.24% |
| Automotive & Ancillaries | Ather Energy Ltd | ATHERENERG |
13.21% |
| RACL Geartech Ltd | RACLGEAR |
5.43% | |
| Sansera Engineering Ltd | SANSERA |
5.28% | |
| Ramkrishna Forgings Ltd | RKFORGE |
4.63% | |
| Rajratan Global Wire Ltd | RAJRATAN |
2.60% | |
| Pharma, Healthcare & CDMO | Solara Active Pharma Sciences Ltd | SOLARA |
3.91% |
| Gland Pharma Ltd | GLAND |
3.80% | |
| Granules India Ltd | GRANULES |
3.01% | |
| Akums Drugs and Pharmaceuticals Ltd | AKUMS |
2.98% | |
| Piramal Pharma Ltd | 543635 |
2.48% | |
| Entero Healthcare Solutions Ltd | ENTERO |
1.25% | |
| Windlas Biotech Ltd | WINDLAS |
1.06% | |
| Aarti Pharmalabs Ltd | AARTIPHARM |
0.99% | |
| Specialty Chemicals | Balaji Amines Ltd | BALAMINES |
4.68% |
| Jubilant Ingrevia Ltd | JUBLINGREA |
4.19% | |
| Industrial & Engineering | Venus Pipes & Tubes Ltd | VENUSPIPES |
3.12% |
| Goodluck India Ltd | GOODLUCK |
3.10% | |
| Universal Cables Ltd | UNIVCABLES |
1.36% | |
| Technology & EMS | RateGain Travel Technologies Ltd | RATEGAIN |
3.65% |
| Cyient DLM Ltd | CYIENTDLM |
2.40% | |
| Consumer Discretionary & Retail | KDDL Ltd | KDDL |
4.71% |
| Packaging & Specialty Films | Cosmo First Ltd | COSMOFIRST |
1.43% |
| Factor / Index Strategy | Motilal Oswal Nifty 500 Momentum 50 ETF | MOMENTUM50 |
3.34% |
| Total Allocation | 100.00% |
| Sector / Strategy Bucket | Number of Positions | Aggregate Weight (%) |
|---|---|---|
| Automotive & Ancillaries | 5 | 31.15% |
| Pharma, Healthcare & CDMO | 8 | 19.48% |
| Commodity / Hedge (Gold) | 1 | 15.24% |
| Specialty Chemicals | 2 | 8.87% |
| Industrial & Engineering | 3 | 7.58% |
| Technology & EMS | 2 | 6.05% |
| Consumer Discretionary | 1 | 4.71% |
| Factor Strategy (Momentum ETF) | 1 | 3.34% |
| Packaging & Specialty Films | 1 | 1.43% |
| Total Portfolio | 24 Holdings | 100.00% |
Execution Over Rigid Multiples: Trimming winners into parabolic moves while preserving a long-term core allows riding multi-year compounding cycles without bearing acute drawdown stress.
Asset Sweating & Margin Inflection: High allocation focus remains on niche manufacturing leaders in auto ancillaries, API CDMOs, and specialty chemicals where operating leverage has troughed.
Capital Protection Framework: A multi-asset balance combining liquid gold, factor indexing, and option hedging provides behavioral comfort and dry powder for opportunistic deployment during market dislocations.
(Disclaimer: I am not a SEBI registered investment advisor. The above holdings reflect personal investments and are shared strictly for academic, educational, and portfolio tracking purposes on ValuePickr. Please conduct your own independent research and risk evaluation before investing.)
